Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects

per Linnebjerg, Helle, LaBell, Elizabeth Smith, Dellva, Mary Anne, Coutant, David E., Leohr, Jennifer
Publicat a Diabetes Ther (2020)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Contro...

per Linnebjerg, Helle, Zhang, Qianyi, LaBell, Elizabeth, Dellva, Mary Anne, Coutant, David E., Hövelmann, Ulrike, Plum-Mörschel, Leona, Herbrand, Theresa, Leohr, Jennifer
Publicat a Clin Pharmacokinet (2020)

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

per Leohr, Jennifer, Dellva, Mary Anne, Coutant, David E., LaBell, Elizabeth, Heise, Tim, Andersen, Grit, Zijlstra, Eric, Hermanski, Lidia, Nosek, Leszek, Linnebjerg, Helle
Publicat a Clin Pharmacokinet (2020)

LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles

per Jin, Yan, Smith, Claire, Hu, Leijun, Coutant, David E., Whitehurst, Kelly, Phipps, Krista, McNearney, Terry Ann, Yang, Xiao, Ackermann, Bradley, Pottanat, Thomas, Landschulz, William
Publicat a Clin Transl Sci (2017)